|
gptkbp:instance_of
|
gptkb:disease
|
|
gptkbp:affects
|
central nervous system
|
|
gptkbp:cause
|
gptkb:unknown
|
|
gptkbp:charity
|
gptkb:National_Multiple_Sclerosis_Society
gptkb:MS_Society_(UK)
gptkb:Multiple_Sclerosis_Foundation
gptkb:MS_International_Federation
|
|
gptkbp:color
|
gptkb:orange
|
|
gptkbp:condition
|
gptkb:depression
anxiety
spasticity
bladder dysfunction
|
|
gptkbp:diagnosis
|
MRI scan
lumbar puncture
|
|
gptkbp:famous_person
|
gptkb:Montel_Williams
gptkb:Ann_Romney
gptkb:Jack_Osbourne
gptkb:Selma_Blair
gptkb:Teri_Garr
|
|
gptkbp:gender
|
more common in women
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Multiple Sclerosis
|
|
gptkbp:influenced_by
|
support groups
stress management
exercise benefits
dietary considerations
|
|
gptkbp:onset_age
|
20 to 40 years
|
|
gptkbp:prevalence
|
2.3 million people worldwide
|
|
gptkbp:public_awareness
|
gptkb:MS_Awareness_Month
|
|
gptkbp:research_focus
|
biomarkers
regenerative medicine
neuroprotection
disease-modifying therapies
|
|
gptkbp:risk_factor
|
smoking
genetic predisposition
viral infections
|
|
gptkbp:symptoms
|
fatigue
difficulty walking
vision problems
numbness
cognitive changes
|
|
gptkbp:treatment
|
gptkb:immunotherapy
corticosteroids
plasma exchange
|
|
gptkbp:type
|
gptkb:Canis_lupus
|
|
gptkbp:type_of
|
primary progressive MS
relapsing-remitting MS
secondary progressive MS
progressive-relapsing MS
|
|
gptkbp:bfsParent
|
gptkb:medical_imaging
gptkb:Jacqueline_du_Pré
|
|
gptkbp:bfsLayer
|
4
|